Back to Results
First PageMeta Content
Food and Drug Administration / Pharmacology / Pharmaceutical industry / Pharmaceuticals policy / FDA Fast Track Development Program / Approved drug / Amyotrophic lateral sclerosis / Orphan drug / Riluzole / Pharmaceutical sciences / Health / Clinical research


Dear (Name of your Congressional and Senatorial Official at the Federal Level), I am writing to express interest in the approval status of a bio-drug produced by Genervon Biopharmaceuticals LLS, known as GM604 or GM6
Add to Reading List

Document Date: 2015-01-15 13:15:12


Open Document

File Size: 123,29 KB

Share Result on Facebook

Company

Genervon Biopharmaceuticals LLS / /

Event

FDA Phase / /

MedicalCondition

terrible disease / ALS / Lou Gehrig’s Disease / disease / amyotrophic lateral sclerosis / /

Organization

FDA / /

Person

Lou Gehrig / /

Position

Senatorial Official / /

Product

Riluzole / GMC6 / GM6 / /

SocialTag